CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Cost-Effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in South Korea
Jung-Yoon Kang, Leejung Choi, Ben Johnson, Hyowon Yang
jbm. 2022;29(2):83-92.   Published online May 31, 2022
DOI: https://doi.org/10.11005/jbm.2022.29.2.83

Excel Download

Cost-Effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in South Korea
Jung-Yoon Kang, Leejung Choi, Ben Johnson, Hyowon Yang
Journal of Bone Metabolism. 2022;29(2):83-92   Crossref logo
Link1 Link2 Link3
Cost-Effectiveness Comparison Of Denosumab And Zoledronic Acid In The Treatment Of Postmenopausal Osteoporosis
Y. Ding, J. Hay
Value in Health. 2014;17(3):A47   Crossref logo
Link1 Link2
Cost-Utility Analysis of Denosumab Versus Alendronate For Postmenopausal Osteoporosis In South Korea
G Bae, H Kwon, J An, J Park
Value in Health. 2018;21:S82   Crossref logo
Link1 Link2
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
B. Jönsson, O. Ström, J. A. Eisman, A. Papaioannou, E. S. Siris, A. Tosteson, J. A. Kanis
Osteoporosis International. 2010;22(3):967-982   Crossref logo
Link1 Link2 Link3
Comment on: cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis
B. Jönsson, O. Ström, J. A. Eisman, A. Papaioannou, E. S. Siris, A. Tosteson, J. A. Kanis
Osteoporosis International. 2011;23(7):2063-2065   Crossref logo
Link1 Link2 Link3
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Ben Johnson, Edward Chia-Cheng Lai, Huang-tz Ou, Hong Li, Björn Stollenwerk
Archives of Osteoporosis. 2021;16(1):   Crossref logo
Link1 Link2 Link3
PMS44 Cost-Effectiveness of Denosumab in the Treatment of Postmenopausal Osteoporosis in Scotland
A. Davies, J. Compston, S. Ferguson, E. McClosky, A. Shearer, A. Taylor
Value in Health. 2011;14(7):A310   Crossref logo
Link1 Link2
Cost-effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in Malaysia
Y. W. Choo, N. A. Mohd Tahir, M. S. Mohamed Said, S. C. Li, M. Makmor Bakry
Osteoporosis International. 2022;   Crossref logo
Link1 Link2 Link3
Cost-Effectiveness of Denosumab for Post-Menopausal Osteoporosis in South Korea
Green Bae, Hye-Young Kwon
Korean Journal of Clinical Pharmacy. 2018;28(2):131-137   Crossref logo
Link1
Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain
Josep Darba, Lisette Kaskens, Francesc Sorio, Mickael Lothgren
ClinicoEconomics and Outcomes Research. 2015;105   Crossref logo
Link1